Frontlight ResearchEarly access
Trial site
Blacktown Cancer and Haematology Centre
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Chronic lymphocytic leukaemia5 trials
- Colorectal cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Follicular lymphoma2 trials
- Gastric and oesophageal cancer2 trials
- Mantle cell lymphoma2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- and 3 more
- Phase
- Phase 15 trials
- Phase 34 trials
- Phase 1/23 trials
- Phase 21 trial
- Status
- Recruiting5 trials
- Completed3 trials
- Terminated3 trials
- Active, not recruiting2 trials
- Lead sponsor
- BeiGene6 trials
- BeOne Medicines6 trials
- ArriVent BioPharma, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia3 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Terminated
Terminated
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Completed
Terminated
Completed
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026